Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
1.050
+0.010 (0.96%)
At close: Jul 19, 2024, 4:00 PM
0.950
-0.100 (-9.52%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cytosorbents Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 2.67, with a low estimate of 1.00 and a high estimate of 4.00. The average target predicts an increase of 154.29% from the current stock price of 1.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 15, 2024.
Analyst Ratings
The average analyst rating for Cytosorbents stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +185.71% | May 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | -4.76% | May 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | -4.76% | Mar 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $5.5 → $1 | Strong Buy → Hold | Downgrades | $5.5 → $1 | -4.76% | Dec 29, 2023 |
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +280.95% | Sep 7, 2023 |
Financial Forecast
Revenue This Year
40.30M
from 36.35M
Increased by 10.85%
Revenue Next Year
47.78M
from 40.30M
Increased by 18.58%
EPS This Year
-0.37
from -0.64
EPS Next Year
-0.21
from -0.37
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 43.4M | 52.3M | 55.0M | 57.3M |
Avg | 40.3M | 47.8M | 53.4M | 55.7M |
Low | 37.0M | 43.4M | 51.3M | 53.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 19.3% | 29.8% | 15.0% | 7.3% |
Avg | 10.9% | 18.6% | 11.7% | 4.3% |
Low | 1.7% | 7.6% | 7.3% | 0.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -0.38 | -0.17 | -0.16 | -0.16 |
Avg | -0.37 | -0.21 | -0.15 | -0.15 |
Low | -0.37 | -0.25 | -0.15 | -0.15 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | - | - | - | - |
Avg | - | - | - | - |
Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.